Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Glynne

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?R Glynne-Jones, J Dunst, D Sebag-Montefiore
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2012
Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation?R Glynne-Jones, N Anyamene, B Moran, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 1990
The 'urn' portal; an alternative to the 'mantle' portal in the chemoradiotherapy management of paediatric Hodgkin's diseaseR Glynne-Jones, S J Whitaker, P N Plowman
The British Journal of Surgery|March 22, 2001
Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancerJ I Geh, A M Crellin, R Glynne-Jones
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2006
Alternative clinical end points in rectal cancer--are we getting closer?R Glynne-Jones, S Mawdsley, T Pearce, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 29, 2013
Association between pretreatment haemoglobin levels and morphometric characteristics of the tumour, response to neoadjuvant treatment and long-term outcomes in patients with locally advanced rectal cancersA A Khan, M Klonizakis, A Shabaan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 1999
A pilot study of continuous, hyperfractionated, accelerated radiotherapy in rectal adenocarcinomaR Glynne-Jones, M I Saunders, P Hoskin, et al.
British Journal of Cancer|February 7, 2008
A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study)J Stebbing, M Harrison, R Glynne-Jones, et al.
Psycho-Oncology|October 6, 1997
Anxiety in long-term cancer survivors influences the acceptability of planned discharge from follow-upS F Thomas, R Glynne-Jones, I Chait, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 16, 1998
Neurological complications of 5-fluorouracil chemotherapy: case report and review of the literatureH A Bygrave, J I Geh, Y Jani, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?R Glynne-Jones, J Dunst, D Sebag-Montefiore
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2012
Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation?R Glynne-Jones, N Anyamene, B Moran, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 1990
The 'urn' portal; an alternative to the 'mantle' portal in the chemoradiotherapy management of paediatric Hodgkin's diseaseR Glynne-Jones, S J Whitaker, P N Plowman
The British Journal of Surgery|March 22, 2001
Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancerJ I Geh, A M Crellin, R Glynne-Jones
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2006
Alternative clinical end points in rectal cancer--are we getting closer?R Glynne-Jones, S Mawdsley, T Pearce, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 29, 2013
Association between pretreatment haemoglobin levels and morphometric characteristics of the tumour, response to neoadjuvant treatment and long-term outcomes in patients with locally advanced rectal cancersA A Khan, M Klonizakis, A Shabaan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 1999
A pilot study of continuous, hyperfractionated, accelerated radiotherapy in rectal adenocarcinomaR Glynne-Jones, M I Saunders, P Hoskin, et al.
British Journal of Cancer|February 7, 2008
A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study)J Stebbing, M Harrison, R Glynne-Jones, et al.
Psycho-Oncology|October 6, 1997
Anxiety in long-term cancer survivors influences the acceptability of planned discharge from follow-upS F Thomas, R Glynne-Jones, I Chait, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 16, 1998
Neurological complications of 5-fluorouracil chemotherapy: case report and review of the literatureH A Bygrave, J I Geh, Y Jani, et al.
Pageof 9